ZA992670B - 4-amino-(ethylamino)-oxindole dopamine autoreceptor agonists. - Google Patents

4-amino-(ethylamino)-oxindole dopamine autoreceptor agonists.

Info

Publication number
ZA992670B
ZA992670B ZA9902670A ZA992670A ZA992670B ZA 992670 B ZA992670 B ZA 992670B ZA 9902670 A ZA9902670 A ZA 9902670A ZA 992670 A ZA992670 A ZA 992670A ZA 992670 B ZA992670 B ZA 992670B
Authority
ZA
South Africa
Prior art keywords
oxindole
ethylamino
amino
dopamine autoreceptor
autoreceptor agonists
Prior art date
Application number
ZA9902670A
Other languages
English (en)
Inventor
James A Nelson
Richard E Mewshaw
Mira A Kanzelberger
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of ZA992670B publication Critical patent/ZA992670B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Psychology (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA9902670A 1998-04-13 1999-04-12 4-amino-(ethylamino)-oxindole dopamine autoreceptor agonists. ZA992670B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5883498A 1998-04-13 1998-04-13

Publications (1)

Publication Number Publication Date
ZA992670B true ZA992670B (en) 2000-10-12

Family

ID=22019205

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9902670A ZA992670B (en) 1998-04-13 1999-04-12 4-amino-(ethylamino)-oxindole dopamine autoreceptor agonists.

Country Status (8)

Country Link
EP (1) EP1073636A1 (xx)
JP (1) JP2002511450A (xx)
CN (1) CN1297439A (xx)
AR (1) AR014847A1 (xx)
AU (1) AU3555099A (xx)
CA (1) CA2327477A1 (xx)
WO (1) WO1999052870A1 (xx)
ZA (1) ZA992670B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7053092B2 (en) 2001-01-29 2006-05-30 Otsuka Pharmaceutical Co., Ltd. 5-HT1a receptor subtype agonist
AR032641A1 (es) * 2001-01-29 2003-11-19 Otsuka Pharma Co Ltd Agonista de subtipo de receptor 5-ht 1a.
AR033485A1 (es) 2001-09-25 2003-12-26 Otsuka Pharma Co Ltd Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma
US8703772B2 (en) 2001-09-25 2014-04-22 Otsuka Pharmaceutical Co., Ltd. Low hygroscopic aripiprazole drug substance and processes for the preparation thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4452808A (en) * 1982-12-07 1984-06-05 Smithkline Beckman Corporation 4-Aminoalkyl-2(3H)-indolones
GB8712073D0 (en) * 1987-05-21 1987-06-24 Smith Kline French Lab Medicament
EP0641202A1 (en) * 1992-05-18 1995-03-08 Smithkline Beecham Plc Use of indolone derivatives for the treatment of memory disorders, sexual dysfunction and parkinson's disease
EP0923551B1 (en) * 1996-08-27 2002-06-05 American Home Products Corporation 4-aminoethoxy indolone derivatives

Also Published As

Publication number Publication date
CN1297439A (zh) 2001-05-30
EP1073636A1 (en) 2001-02-07
JP2002511450A (ja) 2002-04-16
CA2327477A1 (en) 1999-10-21
WO1999052870A1 (en) 1999-10-21
AR014847A1 (es) 2001-03-28
AU3555099A (en) 1999-11-01

Similar Documents

Publication Publication Date Title
MXPA02005101A (es) Derivados de indol canabimimeticos.
GB9921054D0 (en) Indole and indoline derivatives as 5-ht6-selective ligands
DE50014679D1 (de) Substituierte indol-mannichbasen
IL136885A0 (en) 2,3-substituted indole compounds as cox-2 inhibitors
HU9602035D0 (en) Indole derivatives as 5-ht1 agonists
ZA991590B (en) Indole derivatives and pharmaceutical compositions comprising the same.
EP1100493A4 (en) SPLA 2 INHIBITORS? OF THE INDOLTYPS
PT1189583E (pt) Derivados de indol
PT1228041E (pt) Derivados de indol
ZA992670B (en) 4-amino-(ethylamino)-oxindole dopamine autoreceptor agonists.
DZ2917A1 (fr) Nouveau 3-tetrahydropyridin-4-yl indoles.
ZA991893B (en) 5-Heteroaryl substituted indoles.
NO20014127D0 (no) 5-HT1F agonister
AU1937300A (en) Indole derivatives and their use as 5-HT1F agonists
MXPA03004687A (es) Derivados de indol y dihidroindol.
SI1068198T1 (en) 5-heteroaryl substituted indoles
ZA981310B (en) 4-aminoalkoxy-1,3-dihydrobenzoimidazol-2-one dopamine autoreceptor agonists.
DK1214312T3 (da) 5-aminoalkyl- og 5-aminocarbonylsubstituerede indoler
DK1175397T3 (da) 3,3-substituerede indolinderivater
ES1056466Y (es) Aparato etiquetador manual.
AU2002224320A1 (en) 3-substituted oxindole beta 3 agonists
GB0031724D0 (en) Indole derivatives
ES1041562Y (es) Porta-lamparas perfeccionado.
ES1040256Y (es) Camilla perfeccionada.
ES1043313Y (es) Tapon de corcho perfeccionado.